The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| NYXH | -35.06% | N/A | N/A | -80% |
| S&P | +13.09% | +85.73% | +13.17% | +64% |
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $2.30M | 65.7% |
| Gross Profit | -$0.29M | -391.9% |
| Gross Margin | -12.53% | -19.6% |
| Market Cap | $172.17M | -47.5% |
| Market Cap / Employee | $0.94M | 0.0% |
| Employees | 183.6 | 0.0% |
| Net Income | -$27.55M | -47.0% |
| EBITDA | -$26.85M | -69.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $12.77M | -60.1% |
| Accounts Receivable | $3.22M | 15.2% |
| Inventory | 7.1 | 21.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $23.70M | -2.5% |
| Short Term Debt | $1.16M | -32.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -68.90% | -30.8% |
| Return On Invested Capital | -27.29% | 7.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$24.75M | -60.2% |
| Operating Free Cash Flow | -$24.70M | -63.1% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 2.35 | 2.22 | 2.79 | 2.00 | -28.88% |
| Price to Sales | 64.71 | 56.06 | 52.70 | 27.62 | -52.80% |
| Price to Tangible Book Value | 4.47 | 3.99 | 6.19 | 6.67 | 25.03% |
| Enterprise Value to EBITDA | -13.00 | -10.41 | -11.96 | -6.41 | -62.13% |
| Return on Equity | -56.7% | -76.8% | -78.1% | -105.0% | 112.57% |
| Total Debt | $23.46M | $23.86M | $26.30M | $24.86M | -4.51% |
No podcast episodes available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
